Advisor Group Holdings, Inc. Lantern Pharma Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.73 - $10.65 $783 - $2,236	210 Added 105.0%	410 $3,000
Q2 2023 Aug 10, 2023	BUY	$4.56 - $6.02 $911 - $1,204	200 New	200 $1,000
Q3 2022 Nov 14, 2022	SELL	$4.59 - $6.5 $11,456 - $16,224	-2,496 Reduced 74.29%	864 $4,000
Q2 2022 Aug 10, 2022	BUY	$4.82 - $7.45 $1,373 - $2,123	285 Added 9.27%	3,360 $19,000
Q1 2022 May 04, 2022	BUY	$5.6 - $8.22 $1,708 - $2,507	305 Added 11.01%	3,075 $22,000
Q3 2021 Nov 05, 2021	BUY	$10.53 - $14.93 $18,638 - $26,426	1,770 Added 177.0%	2,770 $31,000
Q2 2021 Aug 02, 2021	SELL	$12.94 - $19.89 $3,882 - $5,967	-300 Reduced 23.08%	1,000 $15,000
Q1 2021 May 13, 2021	BUY	$14.34 - $21.92 $18,642 - $28,496	1,300 New	1,300 $24,000

1.29M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $38.3M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.